Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
about
RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense interventionA chemical view of oligonucleotides for exon skipping and related drug applicationsSynthesis and Antisense Properties of Fluoro Cyclohexenyl Nucleic Acid (F-CeNA), a Nuclease Stable Mimic of 2′-Fluoro RNAEvaluation of 2'-Deoxy-2'-fluoro Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy2'-Fluoro RNA shows increased Watson-Crick H-bonding strength and stacking relative to RNA: evidence from NMR and thermodynamic data.Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates.Oligonucleotide-based strategies to combat polyglutamine diseases.Structure/affinity studies in the bicyclo-DNA series: Synthesis and properties of oligonucleotides containing bc(en)-T and iso-tricyclo-T nucleosides.Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.Defining the factors that contribute to on-target specificity of antisense oligonucleotides.Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms.Nuclear factor 90 uses an ADAR2-like binding mode to recognize specific bases in dsRNA.Antisense-based therapy for the treatment of spinal muscular atrophyTargeting RNA splicing for disease therapy.Evolution of thermophilic DNA polymerases for the recognition and amplification of C2'-modified DNA.Hepatotoxic potential of therapeutic oligonucleotides can be predicted from their sequence and modification pattern.ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy.Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization.2'-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF.Exon skipping: a first in class strategy for Duchenne muscular dystrophy.Non-coding RNAs as drug targets.Biological applications of xeno nucleic acids.Specific Increase of Protein Levels by Enhancing Translation Using Antisense Oligonucleotides Targeting Upstream Open Frames.A novel long intergenic noncoding RNA indispensable for the cleavage of mouse two-cell embryos.Synthesis, duplex stabilization and structural properties of a fluorinated carbocyclic LNA analogueSynthesis and duplex-stabilizing properties of fluorinated N-methanocarbathymidine analogues locked in the C3'-endo conformation.Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.miRNA Targeting Drugs: The Next Blockbusters?2'β-Fluoro-Tricyclo Nucleic Acids (2'F-tc-ANA): Thermal Duplex Stability, Structural Studies, and RNase H Activation.Antisense therapeutics: New ways to nudge splicing.Identifying pathway modules of tuberculosis in children by analyzing multiple different networks.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.Conjugation of PEG and gold nanoparticles to increase the accessibility and valency of tethered RNA splicing enhancers
P2860
Q24562489-13E879E3-9E8B-4750-AE91-7FC9DAE51117Q26863684-D1340B6B-25F4-4E3B-9537-0ABF3F6A7613Q27679106-AD7877C1-5A7F-4430-A303-DBD93EBCB216Q28831088-2D9E32CE-6693-4D74-BCC6-BEB562A5BD35Q30572953-2A8BC793-A996-4370-ABE9-667767ED2D8FQ33750824-131EE3B4-0B2F-4DF4-85D8-1FD391878C7BQ33791247-7FEE80D1-1F10-4DB6-A82C-AF6CBDE93043Q34082208-45FB3D30-E05A-4F7D-9CF0-BF1960F44DFEQ34704344-19DBBED3-F104-4145-8D37-262B9EDC5DE6Q35214808-787B9CB7-9902-46E1-AE56-292276DB354AQ35315759-D5272B13-E4D9-4DAE-A6AF-A2EA486D5FB7Q35880220-524F5ADE-5982-47A1-B4B6-08940945A903Q36289113-63913447-842D-4FA7-81B3-0893C5E5177BQ36780738-E253B25C-B9D3-4525-AAD4-0DB7703DDD7AQ36935996-A7A7B62E-DA20-43C3-B10D-37958A881B37Q37139471-87B3FA7A-BEE2-4052-BC1C-B5E6AE3BC5BAQ37271206-44D9F0DF-698C-4180-A3A5-7C04D3337D21Q37733136-7DD4BF73-D4A7-4540-9EC7-644C7F637571Q38299896-FF92B363-1C88-4F2E-BAC5-67F35D954125Q38784820-BCDD5C09-42C4-4A17-A519-3E751BBAEFE7Q38904908-B08C5B13-5906-4B7C-A730-50574CC7C5EFQ39003630-92992A01-247D-4F3B-9669-BAC1C165B85DQ39390082-AEF53660-CBA1-4538-8FE4-74B05B5E12B1Q40633164-D1352417-D34D-458F-A8B9-1FDB267E3EF9Q42158300-E9241386-5CD6-467F-8E96-E942AA1EB09DQ46719115-6FCCF2B9-B8E0-47EE-94A8-3F7BC01BF258Q47784889-3160B7FB-9D43-40A8-A10A-88DF13D8D026Q47968932-623448C9-5E73-45C9-8CA9-EF25EE8617D2Q48182856-8F62CECF-C3E2-4CFD-8BAA-0B45204714A1Q49217769-D507A4F6-D81D-4D8F-A9B1-79F9BE194AD3Q49254712-CE09D79C-085F-47CC-8126-E34EE573E985Q52564290-346ABAFC-0AE6-4694-A82D-6C33FC3F3940Q58830804-43442014-7FEB-45C7-B916-B184FB07B083
P2860
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@ast
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@en
type
label
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@ast
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@en
prefLabel
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@ast
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@en
P2093
P2860
P356
P1476
Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing
@en
P2093
C Frank Bennett
Frank Rigo
Seung J Chun
Thazha P Prakash
P2860
P2888
P304
P356
10.1038/NCHEMBIO.939
P407
P577
2012-04-15T00:00:00Z
P6179
1024361647